Risk Profiling of Breast Cancer-Related Lymphedema (BCRL) in Patients With Breast Cancer Via Using Body Composition and Tissue Dielectric Constant (TDC) Method: A Cross-Sectional Study

IF 2.9 3区 医学 Q2 ONCOLOGY Clinical breast cancer Pub Date : 2024-08-06 DOI:10.1016/j.clbc.2024.08.006
Alper Tuğral , Murat Akyol , Öykü Çolakoğlu , Yeşim Bakar
{"title":"Risk Profiling of Breast Cancer-Related Lymphedema (BCRL) in Patients With Breast Cancer Via Using Body Composition and Tissue Dielectric Constant (TDC) Method: A Cross-Sectional Study","authors":"Alper Tuğral ,&nbsp;Murat Akyol ,&nbsp;Öykü Çolakoğlu ,&nbsp;Yeşim Bakar","doi":"10.1016/j.clbc.2024.08.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Breast Cancer-Related Lymphedema (BCRL) is one of the most prominent long-term side effects of breast cancer (BC) treatment. Although an increased BMI is a well-recognized risk factor for BCRL, there is a lack of knowledge regarding the potential associations between body composition and the risk of BCRL. Therefore, this study aimed to analyze the BCRL risk profiles of surgically operated BC patients via body composition and the Tissue Dielectric Constant (TDC) method, respectively.</div></div><div><h3>Methods</h3><div>A total of 72 patients were included. Patients’ risk for BCRL was assessed with Moisture MeterD (Delfin, Finland) in 4 different probes each has unique penetration depths from 0.5 (10 mm) to 5.0 (55 mm) at both upper extremities. The body composition was analyzed with Tanita-BC-420 (TANITA, Japan). Comparing the dielectric values of extremities and proportioning to one another as TDC ratio (at-risk side/unaffected side) was used to profile BCRL risk.</div></div><div><h3>Results</h3><div>TDC values of the thorax reference point were significantly higher in all four probes on the at-risk side (<em>P</em> &lt; .05). TDC ratios in the forearm and Thorax points were significantly correlated with fat mass (r = 0.256, <em>P</em> = .030; r = 0.269, <em>P</em> = .022) as well as with visceral fat rating (VFR) (r = 0.340, <em>P</em> = .003; <em>r</em> = 0.466, <em>P</em> &lt; .001).</div></div><div><h3>Conclusion</h3><div>This study highlights the need for further care and investigation in the assessment and prediction of BCRL by considering body composition. Since the risk reduction of BCRL can be maximized by considering the individual features, we can conclude that patients with higher body fat irrespective of the BMI should be followed up regularly.</div></div>","PeriodicalId":10197,"journal":{"name":"Clinical breast cancer","volume":"24 8","pages":"Pages 691-698"},"PeriodicalIF":2.9000,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical breast cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1526820924002180","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Breast Cancer-Related Lymphedema (BCRL) is one of the most prominent long-term side effects of breast cancer (BC) treatment. Although an increased BMI is a well-recognized risk factor for BCRL, there is a lack of knowledge regarding the potential associations between body composition and the risk of BCRL. Therefore, this study aimed to analyze the BCRL risk profiles of surgically operated BC patients via body composition and the Tissue Dielectric Constant (TDC) method, respectively.

Methods

A total of 72 patients were included. Patients’ risk for BCRL was assessed with Moisture MeterD (Delfin, Finland) in 4 different probes each has unique penetration depths from 0.5 (10 mm) to 5.0 (55 mm) at both upper extremities. The body composition was analyzed with Tanita-BC-420 (TANITA, Japan). Comparing the dielectric values of extremities and proportioning to one another as TDC ratio (at-risk side/unaffected side) was used to profile BCRL risk.

Results

TDC values of the thorax reference point were significantly higher in all four probes on the at-risk side (P < .05). TDC ratios in the forearm and Thorax points were significantly correlated with fat mass (r = 0.256, P = .030; r = 0.269, P = .022) as well as with visceral fat rating (VFR) (r = 0.340, P = .003; r = 0.466, P < .001).

Conclusion

This study highlights the need for further care and investigation in the assessment and prediction of BCRL by considering body composition. Since the risk reduction of BCRL can be maximized by considering the individual features, we can conclude that patients with higher body fat irrespective of the BMI should be followed up regularly.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用身体成分和组织介电常数 (TDC) 方法对乳腺癌患者的乳腺癌相关淋巴水肿 (BCRL) 进行风险分析:一项横断面研究。
背景:乳腺癌相关性淋巴水肿(BCRL)是乳腺癌(BC)治疗最突出的长期副作用之一。虽然体重指数(BMI)升高是乳腺癌相关淋巴水肿(BCRL)的一个公认风险因素,但人们对身体成分与乳腺癌相关淋巴水肿(BCRL)风险之间的潜在关联还缺乏了解。因此,本研究旨在分别通过身体成分和组织介电常数(TDC)方法分析接受手术治疗的 BCRL 患者的 BCRL 风险概况:方法:共纳入 72 例患者。使用 Moisture MeterD(Delfin,芬兰)的 4 个不同探头评估患者的 BCRL 风险,每个探头在双上肢的穿透深度从 0.5(10 毫米)到 5.0(55 毫米)不等。身体成分用 Tanita-BC-420 (日本 TANITA 公司)进行分析。比较四肢的介电值,并将其相互配比为 TDC 比值(危险侧/未受影响侧),以确定 BCRL 风险:结果:胸部参考点的 TDC 值在风险侧的所有四个探头中都明显较高(P < .05)。前臂点和胸部点的 TDC 比值与脂肪量(r = 0.256,P = .030;r = 0.269,P = .022)以及内脏脂肪评分(VFR)(r = 0.340,P = .003;r = 0.466,P < .001)明显相关:本研究强调了通过考虑身体成分来评估和预测 BCRL 的必要性。由于考虑到个体特征可以最大限度地降低 BCRL 的风险,我们可以得出结论,无论体重指数如何,体脂较高的患者都应定期随访。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical breast cancer
Clinical breast cancer 医学-肿瘤学
CiteScore
5.40
自引率
3.20%
发文量
174
审稿时长
48 days
期刊介绍: Clinical Breast Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of breast cancer. Clinical Breast Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer. Specific areas of interest include clinical research reports from various therapeutic modalities, cancer genetics, drug sensitivity and resistance, novel imaging, tumor genomics, biomarkers, and chemoprevention strategies.
期刊最新文献
Editorial Board Table of Contents Clinical and Imaging Features Associated With Malignant Focal Nonmass Enhancement on Breast MRI. Real-World Outcomes of Pyrotinib-Based Therapy for HER2-Positive Breast Cancer With Brain Metastases: A Multicentre, Retrospective Analysis. Another Biosignature for Ductal Carcinoma In Situ-Have We Moved the Needle?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1